The 4th AntibOZ conference will again have a strong scientific and networking program focussed on identifying new product opportunities and featuring presentations from over 30 leading biopharmaceutical companies, 40 leading International scientists and approximately 90 conference delegates from the biotechnology industry, research institutions, government and academia. AntibOZ-4 will feature leading edge International presentations in biopharmaceutical development plus the latest technologies for antibody optimisation in biopharmaceutical trials. Additional topics to be showcased at the meeting include molecular imaging, targeted delivery and novel biomarker targets, which contribute to the rapid growth in biopharmaceuticals, medical imaging and clinical diagnostics.